These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
976 related items for PubMed ID: 19105418
1. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL. Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418 [Abstract] [Full Text] [Related]
2. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM, Shirokova IE, Lisitskaia TL. Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359 [Abstract] [Full Text] [Related]
4. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS. Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [Abstract] [Full Text] [Related]
5. [Antiphospholipid syndrome and stroke]. Kitagawa Y. Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [Abstract] [Full Text] [Related]
6. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Reshetniak TM, Boĭtsekhovskaia B, Alekberova ZS, Kalashnikova LA, Mach ES, Zabek Ia. Klin Med (Mosk); 1999 Nov; 77(5):32-7. PubMed ID: 10394784 [Abstract] [Full Text] [Related]
7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935 [Abstract] [Full Text] [Related]
8. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. Somers E, Magder LS, Petri M. J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147 [Abstract] [Full Text] [Related]
9. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M. Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121 [Abstract] [Full Text] [Related]
10. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS. Ter Arkh; 2000 Jun; 72(5):34-8. PubMed ID: 11109617 [Abstract] [Full Text] [Related]
11. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study. Stojanovich L, Markovic O, Marisavljevic D, Elezovic I, Ilijevski N, Stanisavljevic N. Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381 [Abstract] [Full Text] [Related]
12. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Tarr T, Lakos G, Bhattoa HP, Szegedi G, Shoenfeld Y, Kiss E. Lupus; 2007 Mar; 16(5):324-8. PubMed ID: 17576733 [Abstract] [Full Text] [Related]
13. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A, Kickler TS, Petri M. J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [Abstract] [Full Text] [Related]